Sign In
Buy GTHX
$7.15
+0 (+0%)
At Close: Dec 16, 2024
Citigroup Inc. Has $325,000 Stock Position in G1 Therapeutics Inc (NASDAQ:GTHX)
09:22am, Tuesday, 24'th Mar 2020
Citigroup Inc. lowered its position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) by 54.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange
G1 Therapeutics (NASDAQ:GTHX) Upgraded by BidaskClub to "Sell"
08:06am, Tuesday, 24'th Mar 2020
G1 Therapeutics (NASDAQ:GTHX) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Tuesday, BidAskClub reports. Other equities research
G1 Therapeutics Inc (NASDAQ:GTHX) Shares Sold by ProShare Advisors LLC
10:06am, Monday, 23'rd Mar 2020
ProShare Advisors LLC reduced its position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) by 9.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exc
G1 Therapeutics Inc (NASDAQ:GTHX) Given Average Recommendation of "Buy" by Brokerages
08:48am, Monday, 23'rd Mar 2020
Shares of G1 Therapeutics Inc (NASDAQ:GTHX) have been assigned a consensus rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat reports. One equities researc
G1 Therapeutics (NASDAQ:GTHX) Cut to "Strong Sell" at BidaskClub
07:44am, Sunday, 22'nd Mar 2020
BidaskClub cut shares of G1 Therapeutics (NASDAQ:GTHX) from a sell rating to a strong sell rating in a report published on Wednesday, BidAskClub reports. A number of other brokerages also recently iss
G1 Therapeutics Inc (NASDAQ:GTHX) Shares Purchased by Charles Schwab Investment Management Inc.
09:54am, Saturday, 14'th Mar 2020
Charles Schwab Investment Management Inc. grew its position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) by 1.7% during the fourth quarter, according to the company in its most recent 13F filing wit
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More
01:33pm, Friday, 13'th Mar 2020
The financial markets are tumbling, event cancellations are mounting, and sports leagues are suspending their seasons. March Madness is in full swing but
Cover Story: Triangle life sciences gasping for capital, leaders
11:12am, Friday, 13'th Mar 2020
There's a growing sense that a major Triangle job sector is hindered by both a lack of VC funding and corporate leadership.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
BRIEF-G1 Therapeutics Announces Appointment Of New Board Member And Chief Commercial Officer
01:59pm, Thursday, 12'th Mar 2020
G1 Therapeutics Inc:
G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer
12:05pm, Thursday, 12'th Mar 2020
G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced the appointments of Jack Bailey to its Board of Directors and Soma Gupta as its Chief Commercial Officer (CCO).
G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer
12:05pm, Thursday, 12'th Mar 2020
- Jack Bailey appointed to Board of Directors- Soma Gupta joins as Chief Commercial Officer- Company reports inducement grant under Nasdaq Listing Rule...
G1 Therapeutics (NASDAQ:GTHX) Rating Lowered to Hold at ValuEngine
08:00am, Thursday, 12'th Mar 2020
G1 Therapeutics (NASDAQ:GTHX) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, ValuE
Barclays PLC Buys 37,531 Shares of G1 Therapeutics Inc (NASDAQ:GTHX)
09:28am, Wednesday, 11'th Mar 2020
Barclays PLC boosted its stake in shares of G1 Therapeutics Inc (NASDAQ:GTHX) by 702.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exc
Edited Transcript of GTHX.O earnings conference call or presentation 26-Feb-20 9:30pm GMT
07:18am, Tuesday, 10'th Mar 2020
Q4 2019 G1 Therapeutics Inc Earnings Call
